|
|
|
|
|
|
c*********p 发帖数: 3217 | 1 昨天的消息说他是,潜在被买的对象.
At this point, it looks like Illumina is content to just sit back and wait
for Roche to continue to bid against itself. Of course the worry for
shareholders is that Roche gets fed up and walks away. Illumina is clearly
the best fit, but there are other fish in the genetic-analysis sea. Life
Technologies (Nasdaq: LIFE ) , Pacific Biosciences of California (Nasdaq:
PACB ) , Complete Genomics (Nasdaq: GNOM ) , and a few smaller private
companies are all potential options. | c*********p 发帖数: 3217 | 2 查了下,同样有被收购潜力的另外两个没动静.
【在 c*********p 的大作中提到】![](/moin_static193/solenoid/img/up.png) : 昨天的消息说他是,潜在被买的对象. : At this point, it looks like Illumina is content to just sit back and wait : for Roche to continue to bid against itself. Of course the worry for : shareholders is that Roche gets fed up and walks away. Illumina is clearly : the best fit, but there are other fish in the genetic-analysis sea. Life : Technologies (Nasdaq: LIFE ) , Pacific Biosciences of California (Nasdaq: : PACB ) , Complete Genomics (Nasdaq: GNOM ) , and a few smaller private : companies are all potential options.
| a*********2 发帖数: 932 | 3 还没有企稳,心中默念鬼火鬼火,不要心动手痒
【在 c*********p 的大作中提到】![](/moin_static193/solenoid/img/up.png) : 昨天的消息说他是,潜在被买的对象. : At this point, it looks like Illumina is content to just sit back and wait : for Roche to continue to bid against itself. Of course the worry for : shareholders is that Roche gets fed up and walks away. Illumina is clearly : the best fit, but there are other fish in the genetic-analysis sea. Life : Technologies (Nasdaq: LIFE ) , Pacific Biosciences of California (Nasdaq: : PACB ) , Complete Genomics (Nasdaq: GNOM ) , and a few smaller private : companies are all potential options.
| c*********p 发帖数: 3217 | 4 高...
【在 a*********2 的大作中提到】![](/moin_static193/solenoid/img/up.png) : 还没有企稳,心中默念鬼火鬼火,不要心动手痒
|
|
|
|
|
|
|